冠状病毒中的重组，以 SARS-CoV-2 为例。
Recombination in Coronaviruses, with a Focus on SARS-CoV-2.
机构信息
North-Western Tuscany Blood Bank, Pisa University Hospital, 56124 Pisa, Italy.
Department of Medicine and Surgery, University of Insubria, 21100 Varese, Italy.
出版信息
Viruses. 2022 Jun 7;14(6):1239. doi: 10.3390/v14061239.
Abstract
Recombination is a common evolutionary tool for RNA viruses, and coronaviruses are no exception. We review here the evidence for recombination in SARS-CoV-2 and reconcile nomenclature for recombinants, discuss their origin and fitness, and speculate how recombinants could make a difference in the future of the COVID-19 pandemics.
摘要
重组是 RNA 病毒常见的进化工具，冠状病毒也不例外。本文回顾了 SARS-CoV-2 中重组的证据，调和了重组体的命名法，讨论了它们的起源和适应性，并推测了重组体在未来 COVID-19 大流行中可能会产生怎样的影响。
Zotero 插件